19-56003953-A-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_153447.4(NLRP5):āc.300A>Cā(p.Glu100Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000177 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_153447.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000181 AC: 45AN: 249252Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135232
GnomAD4 exome AF: 0.000172 AC: 251AN: 1461708Hom.: 0 Cov.: 31 AF XY: 0.000175 AC XY: 127AN XY: 727136
GnomAD4 genome AF: 0.000230 AC: 35AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.300A>C (p.E100D) alteration is located in exon 2 (coding exon 2) of the NLRP5 gene. This alteration results from a A to C substitution at nucleotide position 300, causing the glutamic acid (E) at amino acid position 100 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at